Neal K. Bennett, Moghe Laboratory, Rutgers Biomedical Engineering.

Future Brain Therapies For Parkinson's Possible With Stem Cell Bioengineering Innovation

Article
Brain & Nerve
Behavioral & Mental Health
+2
Contributed byMaulik P. Purohit MD MPHMar 21, 2016

Scientists at Rutgers and Stanford universities have created a new technology that could someday help treat Parkinson's disease and other devastating brain-related conditions that affect millions of people.

The technology -- a major innovation -- involves converting adult tissue-derived stem cells into human neurons on 3-D "scaffolds," or tiny islands, of fibers, said Prabhas V. Moghe, a distinguished professor in the departments of Biomedical Engineering and Chemical and Biochemical Engineering at Rutgers University.

The scaffolds, loaded with healthy, beneficial neurons that can replace diseased cells, were injected into mouse brains.

"If you can transplant cells in a way that mimics how these cells are already configured in the brain, then you're one step closer to getting the brain to communicate with the cells that you're now transplanting," said Moghe, research director for the School of Engineering/Health Sciences Partnerships at Rutgers. "In this work, we've done that by providing cues for neurons to rapidly network in 3-D."

In their multidisciplinary study, published online today in Nature Communications, a dozen scientists from several Rutgers teams and Stanford discuss the 3-D scaffolds and their potentially widespread benefits.

Neurons, or nerve cells, are critical for human health and functioning. Human brains have about 100 billion neurons, which serve as messengers that transmit signals from the body to the brain and vice versa.

Moghe said a 3-D scaffold, developed by the scientists, consists of tiny polymer fibers. Hundreds of neurons attach to the fibers and branch out, sending their signals. Scaffolds are about 100 micrometers wide -- roughly the width of a human hair.

"We take a whole bunch of these islands and then we inject them into the brain of the mouse," he said. "These neurons that are transplanted into the brain actually survived quite miraculously well. In fact, they survived so much better than the gold standard in the field."

Indeed, the scaffold technology results in a 100-fold increase in cell survival over other methods, Moghe said.

And that may eventually help people suffering from Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, Alzheimer's disease, spinal cord and traumatic brain injuries, and concussions, he said.

These diseases and conditions often arise from the loss of brain cells. Parkinson's disease, for example, is caused by the loss of brain cells that produce dopamine, a key neurotransmitter. Brain cell loss can lead to trembling in the hands, arms, legs, jaw and face; rigidity, or stiffness of the limbs and trunk; slowness of movement; and impaired balance and coordination, according to the National Institutes of Health.

The next step would be to further improve the scaffold biomaterials, allowing scientists to increase the number of implanted neurons in the brain. "The more neurons we can transplant, the more therapeutic benefits you can bring to the disease," Moghe said. "We want to try to stuff as many neurons as we can in as little space as we can."

The idea is to "create a very dense circuitry of neurons that is not only highly functioning but also better controlled," he said, adding that testing of mice with Parkinson's disease is underway to see if they improve or recover from the illness.

Eventually, with continued progress, the researchers could perform studies in people. Moghe estimated that it would take 10 to 20 years to test the technology in humans.

Developing the scaffold technology and reprogramming the stem cells in the scaffolds was "very hard team work," he said. "It took many years to get here, so there was a lot of sweat and toil."



The above post is reprinted from materials provided by Rutgers UniversityNote: Materials may be edited for content and length.

Disclaimer: DoveMed is not responsible for the adapted accuracy of news releases posted to DoveMed by contributing universities and institutions.

Primary Resource:

Carlson, A. L., Bennett, N. K., Francis, N. L., Halikere, A., Clarke, S., Moore, J. C., ... & Pang, Z. P. (2016). Generation and transplantation of reprogrammed human neurons in the brain using 3D microtopographic scaffolds. Nature Communications7.

Was this article helpful

On the Article

Maulik P. Purohit MD MPH picture
Approved by

Maulik P. Purohit MD MPH

Assistant Medical Director, Medical Editorial Board, DoveMed Team

0 Comments

Please log in to post a comment.

Related Articles

Test Your Knowledge

Asked by users

Related Centers

Loading

Related Specialties

Loading card

Related Physicians

Related Procedures

Related Resources

Join DoveHubs

and connect with fellow professionals

Related Directories

Who we are

At DoveMed, our utmost priority is your well-being. We are an online medical resource dedicated to providing you with accurate and up-to-date information on a wide range of medical topics. But we're more than just an information hub - we genuinely care about your health journey. That's why we offer a variety of products tailored for both healthcare consumers and professionals, because we believe in empowering everyone involved in the care process.
Our mission is to create a user-friendly healthcare technology portal that helps you make better decisions about your overall health and well-being. We understand that navigating the complexities of healthcare can be overwhelming, so we strive to be a reliable and compassionate companion on your path to wellness.
As an impartial and trusted online resource, we connect healthcare seekers, physicians, and hospitals in a marketplace that promotes a higher quality, easy-to-use healthcare experience. You can trust that our content is unbiased and impartial, as it is trusted by physicians, researchers, and university professors around the globe. Importantly, we are not influenced or owned by any pharmaceutical, medical, or media companies. At DoveMed, we are a group of passionate individuals who deeply care about improving health and wellness for people everywhere. Your well-being is at the heart of everything we do.

© 2023 DoveMed. All rights reserved. It is not the intention of DoveMed to provide specific medical advice. DoveMed urges its users to consult a qualified healthcare professional for diagnosis and answers to their personal medical questions. Always call 911 (or your local emergency number) if you have a medical emergency!